CN105796565B - 一种富马酸亚铁叶酸固体制剂及其制备方法 - Google Patents
一种富马酸亚铁叶酸固体制剂及其制备方法 Download PDFInfo
- Publication number
- CN105796565B CN105796565B CN201410844285.7A CN201410844285A CN105796565B CN 105796565 B CN105796565 B CN 105796565B CN 201410844285 A CN201410844285 A CN 201410844285A CN 105796565 B CN105796565 B CN 105796565B
- Authority
- CN
- China
- Prior art keywords
- folic acid
- ferrous fumarate
- solid pharmaceutical
- pharmaceutical preparation
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 title claims abstract description 264
- 239000011724 folic acid Substances 0.000 title claims abstract description 147
- 235000019152 folic acid Nutrition 0.000 title claims abstract description 147
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 title claims abstract description 118
- 229960000304 folic acid Drugs 0.000 title claims abstract description 118
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 title claims abstract description 98
- 239000011773 ferrous fumarate Substances 0.000 title claims abstract description 97
- 235000002332 ferrous fumarate Nutrition 0.000 title claims abstract description 97
- 229960000225 ferrous fumarate Drugs 0.000 title claims abstract description 97
- 238000002360 preparation method Methods 0.000 title claims abstract description 70
- 239000007787 solid Substances 0.000 title claims abstract description 42
- 239000000825 pharmaceutical preparation Substances 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 claims abstract description 56
- 239000000463 material Substances 0.000 claims abstract description 38
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000003814 drug Substances 0.000 claims abstract description 28
- 229940014144 folate Drugs 0.000 claims abstract description 27
- 239000000843 powder Substances 0.000 claims abstract description 25
- 229910052742 iron Inorganic materials 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 18
- 239000002775 capsule Substances 0.000 claims abstract description 13
- 238000004090 dissolution Methods 0.000 claims abstract description 13
- 229920002472 Starch Polymers 0.000 claims description 45
- 239000008107 starch Substances 0.000 claims description 45
- 235000019698 starch Nutrition 0.000 claims description 45
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 44
- 239000011734 sodium Substances 0.000 claims description 23
- 229910052708 sodium Inorganic materials 0.000 claims description 23
- 235000019359 magnesium stearate Nutrition 0.000 claims description 22
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 18
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 18
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 18
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 18
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims description 13
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 11
- 239000008101 lactose Substances 0.000 claims description 11
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 10
- 229930195725 Mannitol Natural products 0.000 claims description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 10
- 229930006000 Sucrose Natural products 0.000 claims description 10
- 238000009472 formulation Methods 0.000 claims description 10
- 239000000594 mannitol Substances 0.000 claims description 10
- 235000010355 mannitol Nutrition 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 10
- 239000005720 sucrose Substances 0.000 claims description 10
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 9
- 229920000881 Modified starch Polymers 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 9
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 9
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 9
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 8
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 7
- 229910001448 ferrous ion Inorganic materials 0.000 claims description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 7
- 229940069328 povidone Drugs 0.000 claims description 7
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 6
- 239000012456 homogeneous solution Substances 0.000 claims description 6
- 239000012085 test solution Substances 0.000 claims description 6
- 206010044565 Tremor Diseases 0.000 claims description 5
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 5
- 239000001530 fumaric acid Substances 0.000 claims description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 3
- 235000015424 sodium Nutrition 0.000 claims description 3
- 229940079593 drug Drugs 0.000 abstract description 18
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 21
- 238000012360 testing method Methods 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 7
- 241000282472 Canis lupus familiaris Species 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000035935 pregnancy Effects 0.000 description 6
- 206010016880 Folate deficiency Diseases 0.000 description 5
- 208000010188 Folic Acid Deficiency Diseases 0.000 description 5
- 208000007502 anemia Diseases 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000007922 dissolution test Methods 0.000 description 4
- 230000007115 recruitment Effects 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000013020 final formulation Substances 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- JKQOBWVOAYFWKG-UHFFFAOYSA-N molybdenum trioxide Chemical compound O=[Mo](=O)=O JKQOBWVOAYFWKG-UHFFFAOYSA-N 0.000 description 3
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 3
- 229910001948 sodium oxide Inorganic materials 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010022971 Iron Deficiencies Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000036470 plasma concentration Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- OOPLWEDSEDELIX-TYYBGVCCSA-N (e)-but-2-enedioic acid;iron Chemical compound [Fe].OC(=O)\C=C\C(O)=O OOPLWEDSEDELIX-TYYBGVCCSA-N 0.000 description 1
- UQVADGKRJSPTBY-UHFFFAOYSA-N 4-benzyl-5-methoxypyrimidin-2-amine Chemical compound O(C)C=1C(=NC(=NC1)N)CC1=CC=CC=C1 UQVADGKRJSPTBY-UHFFFAOYSA-N 0.000 description 1
- 206010002065 Anaemia megaloblastic Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000000682 Megaloblastic Anemia Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229940063754 folic acid 0.35 mg Drugs 0.000 description 1
- -1 folic acid compound Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000003194 forelimb Anatomy 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 231100001016 megaloblastic anemia Toxicity 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- FBOZXECLQNJBKD-UHFFFAOYSA-N methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000000079 presaturation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
原辅料 | 处方量(10000片) |
叶酸 | 3.5g |
淀粉 | 500.0g |
硬脂酸镁 | 50.0g |
富马酸亚铁(以铁计) | 1000.0g |
羟丙甲纤维素 | 200.0g |
羧甲基淀粉钠 | 100.0g |
原辅料 | 处方量(10000片) |
叶酸 | 3.0g |
乳糖 | 500.0g |
聚维酮 | 30.0g |
硬脂酸镁 | 50.0g |
富马酸亚铁(以铁计) | 1000.0g |
羧甲基淀粉钠 | 100.0g |
原辅料 | 处方量(10000片) |
叶酸 | 4.0g |
乳糖 | 600.0g |
硬脂酸镁 | 50.0g |
富马酸亚铁(以铁计) | 1000.0g |
羟丙甲纤维素 | 200.0g |
羧甲基淀粉钠 | 100.0g |
原辅料 | 处方量(10000片) |
叶酸 | 5.0g |
微晶纤维素 | 500.0g |
滑石粉 | 60.0g |
富马酸亚铁(以铁计) | 1000.0g |
羟丙甲纤维素 | 100.0g |
羧甲基淀粉钠 | 200.0g |
原辅料 | 处方量(10000袋) |
叶酸 | 3.5g |
蔗糖 | 300.0g |
甘露醇 | 300.0g |
矫味剂 | 60.0g |
硬脂酸镁 | 40.0 |
富马酸亚铁(以铁计) | 1000.0g |
羧甲基淀粉钠 | 200.0g |
原辅料 | 处方量(10000片) |
叶酸 | 6.0g |
淀粉 | 500.0g |
硬脂酸镁 | 50.0g |
富马酸亚铁(以铁计) | 1000.0g |
羟丙甲纤维素 | 200.0g |
羧甲基淀粉钠 | 100.0g |
原辅料 | 处方量(10000片) |
叶酸 | 2.0g |
预胶化淀粉 | 500.0g |
硬脂酸镁 | 50.0g |
富马酸亚铁(以铁计) | 1000.0g |
羟丙甲纤维素 | 200.0g |
羧甲基淀粉钠 | 100.0g |
原辅料 | 处方量(10000片) |
叶酸 | 3.5g |
淀粉 | 500.0g |
硬脂酸镁 | 50.0g |
富马酸亚铁(以铁计) | 1000.0g |
羟丙甲纤维素 | 200.0g |
羧甲基淀粉钠 | 100.0g |
原辅料 | 处方量(10000片) |
叶酸 | 3.5g |
淀粉 | 500.0g |
硬脂酸镁 | 50.0g |
富马酸亚铁(以铁计) | 1000.0g |
羟丙甲纤维素 | 200.0g |
羧甲基淀粉钠 | 100.0g |
原辅料 | 处方量(10000片) |
叶酸 | 3.5g |
淀粉 | 500.0g |
硬脂酸镁 | 50.0g |
富马酸亚铁(以铁计) | 1000.0g |
羟丙甲纤维素 | 200.0g |
羧甲基淀粉钠 | 100.0g |
实施例1 | 对比例1 | 对比例2 | 对比例3 | |
Tmax | 45分钟 | 1.5小时 | 1.0小时 | 1.5小时 |
Cmax(ng/mL) | 20.24 | 17.20 | 18.14 | 17.64 |
AUC<sub>(0~∞)</sub>(ng*h/mL) | 106.7 | 82.3 | 90.3 | 85.7 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410844285.7A CN105796565B (zh) | 2014-12-30 | 2014-12-30 | 一种富马酸亚铁叶酸固体制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410844285.7A CN105796565B (zh) | 2014-12-30 | 2014-12-30 | 一种富马酸亚铁叶酸固体制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105796565A CN105796565A (zh) | 2016-07-27 |
CN105796565B true CN105796565B (zh) | 2019-05-28 |
Family
ID=56420105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410844285.7A Active CN105796565B (zh) | 2014-12-30 | 2014-12-30 | 一种富马酸亚铁叶酸固体制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105796565B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109701027A (zh) * | 2019-01-24 | 2019-05-03 | 北京斯利安药业有限公司 | 一种新型的增强叶酸抗氧性的叶酸药物组合物及叶酸药物制剂 |
CN109730323A (zh) * | 2019-03-22 | 2019-05-10 | 北京斯利安药业有限公司 | 铁的氧化物、亚铁盐和/或其组合物在提高叶酸稳定性中的应用 |
CN112335886A (zh) * | 2019-08-06 | 2021-02-09 | 广州富诺营养科技有限公司 | 一种富马酸亚铁叶酸咀嚼片及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101278922A (zh) * | 2008-06-04 | 2008-10-08 | 宛六一 | 一种药物组合物胶囊及其制备方法 |
CN101632675A (zh) * | 2009-08-14 | 2010-01-27 | 海南永田药物研究院有限公司 | 富马酸亚铁叶酸药物组合物及其脂质体固体制剂 |
CN103284164A (zh) * | 2013-06-08 | 2013-09-11 | 哈尔滨珍宝制药有限公司 | 一种含多种维生素和矿物质的组合物 |
CN103356623A (zh) * | 2012-03-26 | 2013-10-23 | 黑龙江福和华星制药集团股份有限公司 | 复方富马酸亚铁和叶酸新型胶囊 |
CN103877115A (zh) * | 2014-02-24 | 2014-06-25 | 蔡伦 | 一种复合维生素组合物、其药物制剂和应用 |
CN104224831A (zh) * | 2014-09-18 | 2014-12-24 | 哈药集团三精制药股份有限公司 | 一种叶酸类营养补充剂的制备方法 |
-
2014
- 2014-12-30 CN CN201410844285.7A patent/CN105796565B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101278922A (zh) * | 2008-06-04 | 2008-10-08 | 宛六一 | 一种药物组合物胶囊及其制备方法 |
CN101632675A (zh) * | 2009-08-14 | 2010-01-27 | 海南永田药物研究院有限公司 | 富马酸亚铁叶酸药物组合物及其脂质体固体制剂 |
CN103356623A (zh) * | 2012-03-26 | 2013-10-23 | 黑龙江福和华星制药集团股份有限公司 | 复方富马酸亚铁和叶酸新型胶囊 |
CN103284164A (zh) * | 2013-06-08 | 2013-09-11 | 哈尔滨珍宝制药有限公司 | 一种含多种维生素和矿物质的组合物 |
CN103877115A (zh) * | 2014-02-24 | 2014-06-25 | 蔡伦 | 一种复合维生素组合物、其药物制剂和应用 |
CN104224831A (zh) * | 2014-09-18 | 2014-12-24 | 哈药集团三精制药股份有限公司 | 一种叶酸类营养补充剂的制备方法 |
Non-Patent Citations (1)
Title |
---|
流化床制粒特点及影响因素;郭良然;《中国药剂学杂志》;20051115;第3卷(第6期);第347页 |
Also Published As
Publication number | Publication date |
---|---|
CN105796565A (zh) | 2016-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2015144285A (ru) | Состав на основе абиратерона ацетата | |
CN105250216B (zh) | 适宜雾化吸入用的盐酸氨溴索注射液 | |
CN105796565B (zh) | 一种富马酸亚铁叶酸固体制剂及其制备方法 | |
CN102552119B (zh) | 一种盐酸氨溴索葡萄糖注射液及其制备方法 | |
CN102085191A (zh) | 一种阿那曲唑口腔崩解片及其制备方法 | |
CN105708829A (zh) | 一种复合维生素氨基酸口服液及其制备方法和应用 | |
CN113077846A (zh) | 一种氯雷他定pbpk模型的建立方法及其应用 | |
CN104940152B (zh) | 一种含有琥珀酸索利那新的药物组合物 | |
CN105496941B (zh) | 一种叶酸固体制剂及其制备方法 | |
CN104661680A (zh) | 化合物及其对食欲控制和胰岛素敏感性的影响 | |
CN101642425A (zh) | 叶酸肠溶制剂组合物及其制备方法 | |
CN106177964B (zh) | 含叶酸葡萄糖酸锌的男性保健组合物及其制剂制备方法 | |
CN113038938B (zh) | 呋喹替尼的药物制剂及其应用 | |
CN111617042A (zh) | 一种复合碳酸钙维生素d3无水吞服颗粒及其制备方法 | |
CN103462887B (zh) | 一种维生素k1注射液及其制备方法 | |
CN100453083C (zh) | 右旋糖酐铁分散片 | |
CN104936585A (zh) | 包括苯肾上腺素和扑热息痛的组合药剂 | |
CN106387915B (zh) | 杞咖益元泡腾片及其制备工艺和应用 | |
CN110522730B (zh) | 一种阿莫西林可溶性粉及其制备方法 | |
CN108703956A (zh) | 一种含有波生坦的固体药物组合物 | |
CN103018190B (zh) | 一种药物制剂及其溶出度测定方法 | |
CN102552210A (zh) | 一种恩替卡韦胶囊及其制备方法 | |
CN109316476A (zh) | 改性米糠醇及其制备方法和应用 | |
CN102204923B (zh) | 一种治疗骨质疏松症的药物组合物 | |
CN102525911B (zh) | 一种溴甲纳曲酮注射液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Ferrous fumarate folic acid solid preparation and preparation method thereof Effective date of registration: 20200122 Granted publication date: 20190528 Pledgee: Beijing Yizhuang International Financing Guarantee Co.,Ltd. Pledgor: BEIJING SILIAN PHARMACEUTICAL INDUSTRY Co.,Ltd. Registration number: Y2020990000097 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210818 Granted publication date: 20190528 Pledgee: Beijing Yizhuang International Financing Guarantee Co.,Ltd. Pledgor: BEIJING SILIAN PHARMACEUTICAL INDUSTRY Co.,Ltd. Registration number: Y2020990000097 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Ferrous fumarate folate solid preparation and preparation method thereof Effective date of registration: 20210818 Granted publication date: 20190528 Pledgee: Beijing Yizhuang International Financing Guarantee Co.,Ltd. Pledgor: BEIJING SILIAN PHARMACEUTICAL INDUSTRY Co.,Ltd. Registration number: Y2021990000732 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230330 Granted publication date: 20190528 Pledgee: Beijing Yizhuang International Financing Guarantee Co.,Ltd. Pledgor: BEIJING SILIAN PHARMACEUTICAL INDUSTRY Co.,Ltd. Registration number: Y2021990000732 |